The Relationship Between DTCA, Drug Requests, and Prescriptions: Uncovering Variation in Specialty and Space

References

• AdAge U.S. ad spending grew 6.5% in 2010 as auto surged and pharma hit a low. (2011) March 17). http://adage.com/article/mediaworks/u-s-ad-spending-grew-6-5-2010-auto-rose-pharma-fell/149436/Google Scholar
• Aikin KJ, Swasy JL, Braman AC. Patient and physician attitudes and behaviors associated with DTC promotion of prescription drugs—Summary of FDA survey research results. (2004) . Executive Summary, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Washington, DCGoogle Scholar
• Amaldoss W, He C. Direct-to-consumer advertising of prescription drugs: A strategic analysis. Marketing Sci. (2009) 28(3):472–487Link, Google Scholar
• Armitage KJ, Schneidermann LJ, Bass RA. Response of physicians to medical complaints in men and women. J. Amer. Medical Assoc. (1979) 241(20):2186–2187Crossref, Google Scholar
• Atherly A, Rubin PH. The cost-effectiveness of direct-to-consumer advertising for prescription drugs. Medical Care Res. Rev. (2009) 66(6):639–657Crossref, Google Scholar
• Ayanian J, Epstein A. Differences in the use of procedures between women and men hospitalized for coronary artery disease. New England J. Medicine (1991) 325(4):221–225Crossref, Google Scholar
• Bajari P. A comment on Allenby, Chen and Yang. Quant. Marketing Econom. (2003) 1(2):277–283Crossref, Google Scholar
• Barg FK, Greir SA. Enhancing breast cancer communications: A cultural models approach. Internat. J. Res. Marketing (2008) 25(4):335–342Crossref, Google Scholar
• Bell RA, Kravitz RL, Wilkes MS. Direct-to-consumer prescription drug advertising and the public. J. General Internal Medicine (1999a) 14(11):651–657Crossref, Google Scholar
• Bell RA, Wilkes MS, Kravitz RL. Advertisement-induced prescription drug requests: Patients' anticipated reactions to a physician who refuses. J. Family Practice (1999b) 48(6):446–452Google Scholar
• Berger JT, Kark P, Rosner F, Packer S, Bennett AJ. Direct to consumer drug marketing: Public service or disservice? Mount Sinai J. Medicine (2001) 68(3):197–202Google Scholar
• Berry ST. Estimating discrete-choice models of product differentiation. RAND J. Econom. (1994) 25(2):242–262Crossref, Google Scholar
• Berry ST. Comment on “Bayesian analysis of simultaneous demand and supply” by Sha Yang, Yuxin Chen, Greg M. Allenby. Quant. Marketing Econom. (2003) 1(3):285–291Crossref, Google Scholar
• Berry ST, Levinsohn J, Pakes A. Automobile prices in market equilibrium. Econometrica (1995) 63(4):841–890Crossref, Google Scholar
• Bowser R. Racial profiling in health care: An institutional analysis of medical treatment. Michigan J. Race Law (2001) 7:79–133Google Scholar
• Brekke KR, Kuhn M. Direct to consumer advertising in pharmaceutical markets. J. Health Econom. (2006) 25(1):102–130Crossref, Google Scholar
• Brooks SP, Gelman A. General methods for monitoring convergence of iterative simulations. J. Comput. Graph. Statist. (1998) 7(4):434–455Google Scholar
• Broyles RW, McAuley WJ, Baird-Holmes D. The medically vulnerable: Their health risks, health status, and use of physician care. J. Health Care Poor Underserved (1999) 10(2):186–200Crossref, Google Scholar
• Calabro S. In DTC-free Europe, just as many patients ask for brand drugs. Medical Marketing Media (2003) 38(11):3Google Scholar
• Camacho N, Landsman V, Stremersch S, Wuyts S, Dekimpe MG, Gijsbrecht E, Pieters R. The connected patient. The Connected Customer: The Changing Nature of Consumer and Business Markets (2010) (Routledge Academic, London) Google Scholar
• Calfee JE, Winston C, Stempski R. Direct-to-consumer advertising and the demand for cholesterol-reducing drugs. J. Law Econom. (2002) 45(S2):673–690Crossref, Google Scholar
• Cantor J. Does direct to consumer advertising of antidepressants affect visits to physicians? (2010) . Working paper, Cornell University, Ithaca, NYGoogle Scholar
• Cartwright A. Community and the public body in breast cancer media activism. Cultural Stud. (1998) 12(2):117–138Crossref, Google Scholar
• Centers for Disease Control and Prevention Health, United States, 2010—With special feature on death and dying. (2010) . Report, National Center for Health Statistics, U.S. Department of Health and Human Services, Hyattsville, MDGoogle Scholar
• Chintagunta P, Dubé J-P, Goh KY. Beyond the endogeneity bias: The effect of unmeasured brand characteristics on household-level brand choice models. Management Sci. (2005) 51(5):832–849Link, Google Scholar
• Cohen MG, Fonarow GC, Peterson ED, Moscucci M, Dai D, Hernandez AF, Bonow RO, Smith SC. Racial and ethnic differences in the treatment of acute myocardial infarction: Findings from the Get with the Guidelines Coronary Artery Disease Program. Circulation (2010) 121(21):2294–2301Crossref, Google Scholar
• Cooper-Patrick L, Gallo JJ, Gonzales JJ, Vu HT, Powe NR, Nelson C, Ford DE. Race, gender, and partnership in the patient-physician relationship. J. Amer. Medical Assoc. (1999) 282(6):583–589Crossref, Google Scholar
• Coscelli A. The importance of doctors' and patients' preferences in the prescription decision. J. Indust. Econom. (2000) 48(3):349–369Crossref, Google Scholar
• Daugird AJ, Crowell K. Do statins cause myopathy? J. Family Practice (2003) 52(12):973–977Google Scholar
• Deveugele M, Derese A, van den Brink A, Bensing J, De Maeseneer J. Consultation length in general practice: Cross sectional study in six European countries. British Medical J. (2002) 325(7362):472–477Crossref, Google Scholar
• Ding M, Eliashberg J. A dynamic competitive forecasting model incorporating dyadic decision making. Management Sci. (2008) 54(4):820–834Link, Google Scholar
• Donohue JM, Berndt ER. Effects of direct-to-consumer advertising on medication choice: The case of antidepressants. J. Public Policy Marketing (2004) 23(2):115–127Crossref, Google Scholar
• Draganska Jain MD. Structural models of competitive market behavior: An estimation approach using disaggregate data. (2002) . Working paper, Stanford University, Stanford, CAGoogle Scholar
• Dubé JP, Chintagunta PK. Comment on Bayesian analysis of simultaneous demand and supply. Quant. Marketing Econom. (2003) 1(3):293–298Crossref, Google Scholar
• Fischer M, Albers S. Patient- or physician-oriented marketing: What drives primary demand for prescription drugs? J. Marketing Res. (2010) 47(1):103–121Crossref, Google Scholar
• Gould SJ. Consumer attitudes toward health and health care: A differential perspective. J. Consumer Affairs (1988) 22(1):96–118Crossref, Google Scholar
• Hannan EL, Kilburn H, O'Donnell JF, Lukacik G, Shields EP. Interracial access to selected cardiac procedures for patients hospitalized with coronary artery disease in New York state. Medical Care (1991) 29(5):430–441Crossref, Google Scholar
• Hannan EL, van Ryn M, Burke J, Stone D, Kumar D, Arani D, Pierce W, et al. Access to coronary artery bypass surgery by race/ethnicity and gender among patients who are appropriate for surgery. Medical Care (1999) 37(1):68–77Crossref, Google Scholar
• Helman CG. Culture, Health and Illness (1994) 3rd ed.(Butterworth-Heinemann Ltd., Oxford, UK) Google Scholar
• Hildebrand V, Van Kerm P. Income inequality and self-rated health status: Evidence from the European community household panel. Demography (2009) 46(4):805–825Crossref, Google Scholar
• Hollon MF. Direct-to-consumer marketing of prescription drugs: Creating consumer demand. J. Amer. Medical Assoc. (1999) 281(4):382–384Crossref, Google Scholar
• Hooper EM, Comstock LM, Goodwin JM, Goodwin JS. Patient characteristics that influence physician behavior. Medical Care (1982) 20(6):630–638Crossref, Google Scholar
• Hosken D, Wendling B. Informing the uninformed: How drug advertising affects check-up visits. Internat. J. Indust. Organ. (2010) . ePub ahead of print December 2Google Scholar
• Iizuka T, Jin GZ. The effect of prescription drug advertising on doctor visits. J. Econom. Management Strategy (2005) 14(3):701–727Crossref, Google Scholar
• IMS Health. IMS study: U.S. physicians responsive to patient requests for brand-name drugs. (2002) . Press release (April 1), IMS Health, Fairfield, CTGoogle Scholar
• Janakiraman R, Dutta S, Sismeiro C, Stern P. Physicians' persistence and its implications for their response to promotion of prescription drugs. Management Sci. (2008) 54(6):1080–1093Link, Google Scholar
• Kaplan SH, Gandek B, Greenfield S, Rogers W, Ware JE. Patient and visit characteristics related to physicians' participatory decision-making style. Medical Care (1995) 33(12):1176–1187Crossref, Google Scholar
• Koch-Laking A, Park MK, Tweed E. Does DTC advertising affect physician prescribing habits? Clinical Inquiries (2010) 59(11):649–650Google Scholar
• Kolsarici C, Vakratsas D. Category-versus brand-level advertising messages in a highly regulated environment. J. Marketing Res. (2010) 47(6):1078–1089Crossref, Google Scholar
• Kravitz RL. Direct-to-consumer advertising of prescription drugs: Implications for the patient-physician relationship. J. Amer. Medical Assoc. (2000) 284(17):2244Crossref, Google Scholar
• Kravitz RL, Bell RA, Azari R, Kelly-Reif S, Krupat E, Thom DH. Direct observation of requests for clinical services in office practice: What do patients want and do they get it? Arch. Internal Medicine (2003) 163(14):1673–1681Crossref, Google Scholar
• Kravitz RL, Epstein RM, Feldman MD, Franz CE, Azari R, Wilkes MS, Hinton L, Franks P. Influence of patients' requests for direct-to-consumer advertised antidepressants. J. Amer. Medical Assoc. (2005) 293(16):1995–2002Crossref, Google Scholar
• Kremer STM, Bijmolt THA, Leeflang PSH, Wieringa JE. Generalizations on the effectiveness of pharmaceutical promotional expenditures. Internat. J. Res. Marketing (2008) 25(4):234–246Crossref, Google Scholar
• Lillie-Blanton M, Brodie M, Rowland D, Altman D, McIntosh M. Race, ethnicity, and the health care system: Public perceptions and experiences. Medical Care Res. Rev. (2000) 57(Supplemet 1):218–235Crossref, Google Scholar
• Ling DC, Berndt ER, Kyle MK. Deregulating direct-to-consumer marketing of prescription drugs: Effects on prescription and over-the-counter product sales. J. Law Econom. (2002) 45(2):691–723Crossref, Google Scholar
• Liu Q, Gupta S. The impact of direct-to-consumer advertising of prescription drugs on physician visits and drug requests: Empirical findings and public policy implications. Internat J. Res. Marketing (2011) 28(3):205–217Crossref, Google Scholar
• Lupton D. Consumerism, reflexivity and the medical encounter. Social Sci. Medicine (1997) 45(3):373–381Crossref, Google Scholar
• Macias W, Lewis LS. A content analysis of direct to consumer (DTC) prescription drug Web sites. J. Advertising (2003) 32(4):43–55Crossref, Google Scholar
• Mack J. The empowered patient: What it means for pharma marketers. Pharma Marketing News (2009) 8(4):2–7Google Scholar
• Manchanda P, Rossi PE, Chintagunta PK. Response modeling with nonrandom marketing-mix variables. J. Marketing Res. (2005) 41(4):467–478Crossref, Google Scholar
• Manchanda P, Xie Y, Youn N. The role of targeted communication and contagion in product adoption. Marketing Sci. (2008) 27(6):961–976Link, Google Scholar
• Mastin T, Andsager JL, Choi J, Lee K. Health disparities and direct-to-consumer prescription drug advertising: A content analysis of targeted magazine genres, 1992–2002. Health Comm. (2007) 22(1):49–58Crossref, Google Scholar
• McKillen D. Consumers depend on brand-specific Web sites for information. Medical Marketing Media (2002) 37(5):12–14Google Scholar
• McKinlay J. Some contributions from the social system to gender inequalities in heart disease. J. Health Soc. Behav. (1996) 37(1):1–26Crossref, Google Scholar
• Medical Marketing and Media DTC success measured by drug requests. Medical Marketing Media (2002) 37(6):6Google Scholar
• Meyerhoefer CD, Zuvekas SH. The shape of demand: What does it tell us about direct-to-consumer marketing of antidepressants? B.E. J. Econom. Anal. Policy (2008) 8(2). Article 4Google Scholar
• Mintzes B, Barer ML, Kravitz RL, Bassett B, Lexchin J, Kazanjian A, Evans RG, Pan R, Marion SA. How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA. Canadian Medical Assoc. J. (2003) 169(5):405–412Google Scholar
• Mizik N, Jacobson R. Are physicians “easy marks”? Quantifying the effects of detailing and sampling on new prescriptions. Management Sci. (2004) 50(12):1704–1715Link, Google Scholar
• Mundy A. Making a name for drugs without using their names; Some ads highlight only Web addresses so side effects don't have to be listed. Wall Street Journal (2008) 29(August):B.1Google Scholar
• Musalem A, Bradlow E, Raju J. Who's got the coupon? Estimating consumer preferences and coupon usage from aggregate data. J. Marketing Res. (2008) 45(6):715–730Crossref, Google Scholar
• Nevo A. Measuring market power in the ready-to-eat cereal industry. Econometrica (2001) 69(2):307–342Crossref, Google Scholar
• Omonuwa SC. Health disparity in black women: Lack of pharmaceutical advertising in black- vs. white-oriented magazines. J. Natl. Medical Assoc. (2001) 93(7–8):263–266Google Scholar
• Parnes B, Smith PC, Gilroy C, Quintela J, Emsermann CB, Dickinson LM, Westfall JM. Lack of impact of direct-to-consumer advertising on the physician-patient encounter in primary care: A SNOCAP report. Ann. Family Medicine (2009) 7(1):41–46Crossref, Google Scholar
• Paterniti DA, Fancher TL, Cipri CS, Timmermans S, Heritage J, Kravitz RL. Getting to “no”. Archives Internal Medicine (2010) 170(4):381–388Crossref, Google Scholar
• Peterson E, Shaw L, DeLong E, Pryor D, Califf R, Mark D. Racial variation in the use of coronary-revascularization procedures—Are the differences real? Do they matter? New Eng. J. Medicine (1997) 336(7):480–486Crossref, Google Scholar
• Prosser H, Almonda S, Walley T. Influences on GPs' decision to prescribe new drugs—The importance of who says what. Family Practice (2003) 20(1):61–68Crossref, Google Scholar
• Rama JK, Singh J. Pragmatic learning theory: An inquiry-action framework for distributed consumer learning in online communities. J. Consumer Res. (2010) 36(April):1058–1081Google Scholar
• Rosenthal MB, Berndt ER, Donohue JM, Epstein AM, Frank RG, Cutler DM, Garber AM. Demand effects of recent changes in prescription drug information. Frontiers in Health Policy Research (2003) 6(MIT Press, Boston) 1–26Google Scholar
• Schwartz RK, Soumerai SB, Avorn J. Physician motivations for nonscientivic drug prescribing. Soc. Sci. Medicine (1989) 28(6):577–582Crossref, Google Scholar
• Sehili S, Elbasha EH, Moriarty DG, Zack MM. Inequalities in self-reported physical health in the United States, 1993–1999. Health Econom. (2004) 14(4):377–389Crossref, Google Scholar
• Sonel AF, Good CB, Mulgund J, Roe MT, Gibler WB, Smith SC, Cohen MG, Pollack CV, Ohman EM, Peterson ED. Racial variations in treatment and outcomes of black and white patients with high-risk non–ST-elevation acute coronary syndromes: Insights from CRUSADE (can rapid risk stratification of unstable angina patients suppress adverse outcomes with early implementation of the ACC/AHA guidelines?). Circulation (2005) 111:1225–1232Google Scholar
• Steingart R. Sex differences in management of coronary artery disease. New England J. Medicine (1991) 325(4):221–225Crossref, Google Scholar
• Stevenson FA, Barry AC, Britten N, Barber N, Bradley CP. Doctor-patient communication about drugs: the evidence for shared decision making. Soc. Sci. Medicine (2000) 50:829–840Crossref, Google Scholar
• Street RL, Buller DB. Patients' characteristics affecting physician-patient nonverbal communication. Human Comm. Res. (1988) 15(1):60–90Crossref, Google Scholar
• Street RL, Gordon HS, Ward MM, Krupat E, Kravitz RL. Patient participation in medical consultations: Why some patients are more involved than others. Medical Care (2005) 43(10):960–969Crossref, Google Scholar
• Stremersch S, Van Dyck W. Marketing of the life sciences: A new framework and research agenda for a nascent field. J. Marketing (2009) 73(4):4–30Crossref, Google Scholar
• Sudhir K. Structural analysis of competitive pricing in the presence of a strategic retailer. Marketing Sci. (2001) 20(3):244–264Link, Google Scholar
• Tamayo-Sarver JH, Hinze SW, Cydulka RK, Baker DW. Racial and ethnic disparities in emergency department analgesic prescription. Amer. J. Public Health (2003) 93(12):2067–2073Crossref, Google Scholar
• Tentler A, Silberman J, Paterniti DA, Kravitz RL, Epstein RM. Factors affecting physicians' responses to patients' requests for antidepressants: Focus group study. J. General Internal Medicine (2008) 23(1):51–57Crossref, Google Scholar
• Todd KH, Samaroo N, Hoffman JR. Ethnicity as risk factor for inadequate emergency department analgesia. J. Amer. Medical Assoc. (1993) 269(12):1537–1539Crossref, Google Scholar
• Uhlmann RF, Inui TS, Pecoraro RE, Carter WB. Relationship of patient request fulfillment to compliance, glycemic control, and other health care outcomes in insulin-dependent diabetes. J. Internal Medicine (1988) 3(5):458–463Google Scholar
• Vakratsas D, Ambler T. How advertising works: What do we really know? J. Marketing (1999) 63(1):26–43Crossref, Google Scholar
• Van Ryn M, Burke J. The effect of patient race and socio-economic status on physicians' perceptions of patients. Soc. Sci. Medicine (2000) 50:813–828Crossref, Google Scholar
• Venkataraman S, Stremersch S. The debate on influencing doctors' decisions: Are drug characteristics the missing link? Management Sci. (2007) 53(11):1688–1701Link, Google Scholar
• Ventres W, Gordon P. Communication strategies in caring for the underserved. J. Health Care for the Poor and Underserved (1990) 1:305–314Crossref, Google Scholar
• Villas-Boas JM, Winer RS. Endogeneity in brand choice models. Management Sci. (1999) 45(October):1324–1338Link, Google Scholar
• Villas-Boas JM, Zhao Y. Retailer, manufacturers, and individual consumers: Modeling the supply side in the ketchup marketplace. J. Marketing Res. (2005) 42(1):83–95Crossref, Google Scholar
• Wang SS. Drug-safety data: Too much information? The Wall Street Journal (2008) 9(December):D.1Google Scholar
• Webb S, Lloyd M. Prescribing and referral in general practice: A study of patients' expectations and doctors' actions. British J. General Practice (1994) 44:165–169Google Scholar
• Weiss MC, Fitzpatrick R, Scott DK, Goldacre MJ. Pressures on the general practitioner and decisions to prescribe. Family Practice (1996) 13(5):432–438Crossref, Google Scholar
• Weissman JS, Blumenthal D, Silk AJ, Zapert K, Newman M, Leitman R. Consumers' reports on the health effects of direct-to-consumer drug advertising. Health Affairs (2004) W3(Suppl. Web Exclusives):82–95Google Scholar
• Welch Cline J, Young HN. Marketing drugs, marketing health care relationships: A content analysis of visual cues in direct-to-consumer prescription drug advertising. Health Comm. (2004) 16(2):131–157Crossref, Google Scholar
• Wenneker M, Epstein A. Racial inequalities in the use of procedures for patients with ischemic heart disease in Massachusetts. J. Amer. Medical Assoc. (1989) 261(2):253–257Crossref, Google Scholar
• Werner RM, Asch DA, Polsky D. Racial profiling: The unintended consequences of coronary artery bypass graft report cards. Circulation (2005) 111:1257–1263Google Scholar
• Wilkes MS, Bell RA, Kravitz RL. Direct-to-consumer prescription drug advertising: Trends, impact, and implications. Health Affairs (2000) 19(2):110–128Crossref, Google Scholar
• Wosinska M. Direct-to-consumer advertising and drug therapy compliance. J. Marketing Res. (2005) 42(3):323–332Crossref, Google Scholar
• Yang S, Allenby G. Modeling interdependent consumer preferences. J. Marketing Res. (2003) 40(3):282–294Crossref, Google Scholar
• Yang S, Chen Y, Allenby G. Bayesian analysis of simultaneous demand and supply. Quant. Marketing Econom. (2003) 1:251–275Crossref, Google Scholar
• Young M, Klingle RS. Silent partners in medical care: A cross-cultural study of patient participation. Health Comm. (1996) 8(1):29–35Crossref, Google Scholar
• Zachry WM, Shepherd MD, Hinich MJ, Wilson JP, Brown CM, Lawson KA. Relationship between direct-to-consumer advertising and physician diagnosing and prescribing. Amer. J. Health-System Pharmacy (2002) 59(1):42–49Crossref, Google Scholar